The authorisation to manage a blood depot referred to in article L. 1221-10 is granted by the regional health agency with territorial jurisdiction, after obtaining the opinion of the Etablissement français du sang for the health establishments and health cooperation groups referred to in article L. 6133-1. When a health establishment or a health cooperation group applies for authorisation to manage a blood depot, it first signs an agreement with the referring blood establishment relating to the operation of the depot and the procedures for monitoring the labile blood products stored. This agreement takes effect on the date of authorisation of the blood establishment.
An order by the Minister for Health, issued after consultation with the President of the Etablissement Français du Sang (French Blood Establishment), the Director of the Armed Forces Blood Transfusion Centre and the Director General of the Agence Nationale de Sécurité du Médicament et des Produits de Santé (National Agency for the Safety of Medicines and Health Products), defines the standard model of the agreement, which must include clauses relating to the operation of the blood depot, the staff and their qualifications and the equipment used to store labile blood products.